6-(Piperidin-1-yl)benzo[d]thiazole

Catalog No.: 
ACADNM091
CAS No.: 
663627-30-3
Molecular Formula: 
C12H14N2S
Molecular Weight: 
218.32
6-(Piperidin-1-yl)benzo[d]thiazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$358.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-(Piperidin-1-yl)benzo[d]thiazole
IUPAC Name6-(piperidin-1-yl)benzo[d]thiazole
MDL No.MFCD11846172
Molecular FormulaC12H14N2S
Molecular Weight218.32
SMILESC12=CC=C(N3CCCCC3)C=C1SC=N2
InChI KeyOGBXIDWJHRBZJK-UHFFFAOYSA-N
SynonymBenzothiazole, 6-(1-piperidinyl)- (9CI);6-(Piperidin-1-yl)benzo[d]thiazole;Benzothiazole, 6-(1-piperidinyl)-
CAS No.663627-30-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACADNM091 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRONU647 route compound structure diagram
    ACRONU64753218-26-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACADNM091 route product structure diagram
    ACADNM091663627-30-3
Inquiry

2. ACADNM091 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACUFCL270 route compound structure diagram
    ACUFCL270111-24-0In Stock
  2. Plus
  3. ACMFKG874 route compound structure diagram
    ACMFKG874533-30-2In Stock
  4. Then
  5. ACADNM091 route product structure diagram
    ACADNM091663627-30-3
Inquiry

3. ACADNM091 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYHOL185 route compound structure diagram
    ACYHOL185628-77-3In Stock
  2. Plus
  3. ACMFKG874 route compound structure diagram
    ACMFKG874533-30-2In Stock
  4. Then
  5. ACADNM091 route product structure diagram
    ACADNM091663627-30-3
Inquiry

Comments (0)